作為JANUS激酶抑制劑的雜芳基取代的吡咯並[2，3-B]吡啶和吡咯並[2，3-B]嘧啶

• 收藏
• 分享

专利权人:

INCYTE HOLDINGS CORPORATION

发明人:

RODGERS, JAMES D.,SHEPARD, STACEY,MADUSKUIE, THOMAS P.,WANG, HAISHENG,FALAHATPISHEH, NIKOO,RAFALSKI, MARIA,ARVANITIS, ARGYRIOS G.,STORACE, LOUIS,JALLURI, RAVI KUMAR,FRIDMAN, JORDAN S.,VADDI, KRISHNA

申请号：

HK12100362.6

公开号：

HK1160111B

申请日:

2012.01.12

申请国别(地区):

HK

年份:

2016

代理人:

摘要：

The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines (I) and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/